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Abstract 
Objectives: This study aimed to investigate and compare the prevalence of oral mucosal lesions in a group of pso-
riatic patients and healthy subjects, and its correlation to multiple clinical parameters.
Study design: 100 psoriatic patients and 100 closely matched controls underwent clinical oral examination.  Oral 
lesions were diagnosed according to the criteria proposed by the World Health Organization (WHO).  The patients 
filled the Hospital Anxiety and Depression (HAD) questionnaire and the Dermatology Life Quality Index (DLQI). 
The severity of psoriasis was assessed by the Psoriasis Area and Severity Index (PASI).  Categorical variables were 
evaluated using Chi-square test or Fisher’s exact test with overall significance set at p< 0.05. 
Results: Oral mucosal lesions were diagnosed in 43 (43%) psoriatic patients and 17 (17%) control subjects 
(p=0.000).  Comparing psoriatic patients to control subjects the prevalence of fissured tongue (FT) was 35% vs. 
13% (p=0.000); geographic tongue (GT) 17% vs. 9% (p=0.09); combination of FT and GT 5% vs. 5% (p=1.00); 
oral candidosis 3% vs. 0% (p=0.81); leukoedema 1% vs. 3% (p=0.62); physiologic melanin pigmentations 4% vs. 
1% (p=0.37) respectively. The clinical type of psoriasis, duration of the disease, method of disease management 
(medicated vs. non-medicated for psoriasis), smoking habit, psychological status or the disease severity did not in-
fluence the prevalence of FT and GT.  Psoriatic patients who experienced “very large” to “extremely large” adverse 
effect of psoriasis on their quality of life have significantly higher prevalence of GT (p=0.04).
Conclusions: FT is significantly more common in psoriatic patients compared to controls; hence studies investiga-
ting the nature of this relationship are warranted. Oral health care providers should be aware of the predisposition 
of psoriatic patients to oral candidosis.
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Introduction 
Psoriasis is a common multisystem inflammatory chro-
nic disease with predominantly skin and joint manifes-
tations.  The estimated prevalence of psoriasis ranges 
between 0.5% and 4.6% with geographic and ethnic va-
riations (1).  Psoriasis is classified clinically into several 
types such as plaque type (also known as psoriasis vul-
garis), inverse, erythrodermic, pustular, guttate, psoria-
tic onychodystrophy and psoriatic arthritis.  The plaque 
type is the most common form of the disease affecting 
up to 90% of the cases (1).
The dermatological and joint manifestations of the di-
sease are well documented, but whether psoriasis has 
oral manifestations (2,3), or not (4,5) is still a subject 
of controversy. Various oral lesions, such as geographic 
tongue (GT) (2,6-8), fissured tongue (FT) (2,3,9), and 
to less extent leukoedema (LD) and physiologic mela-
nin pigmentation (3), have been described with higher 
prevalence in psoriatic patients compared to control 
subjects.  Oral mucosal psoriasis, as proved by histopa-
thological testing, has been recently reported in patients 
without cutaneous psoriatic lesions (10). 
Reviewing the literature reveals lack of consensus regar-
ding the association of oral lesions with a certain clinical 
type of skin psoriasis (2,3,9,11).  One study suggested a 
positive correlation between the prevalence of oral le-
sions and the severity of the psoriasis as assessed by the 
Psoriasis Area and Severity Index (PASI) (9).  The pso-
riasis is known to have a profound impact on the quality 
of the patient’s life (12), but the relationship of oral le-
sions to the Dermatology Life Quality Index (DLQI) has 
not been evaluated in psoriatic patients before.  Therefo-
re, the aims of this study were to assess the prevalence of 
oral mucosal lesions in psoriatic patients in comparison 
with a control group closely matched for age and gender, 
and to explore any association with the type of psoria-
sis, duration of psoriasis, severity of the disease, disease 
onset, type of psoriasis treatment, and tobacco smoking 
habit.  The study also aimed to evaluate the psychologi-
cal status of psoriatic patients (presence of anxiety and 
depression), and patient’s life quality as a sequence to 
psoriasis and their relationship to the oral lesions.
Material and Methods
The subjects of the study group were adult patients diag-
nosed with psoriasis by their dermatologist, recruited 
consecutively from patients attending the Dermatology 
Clinics at King Abdullah University Hospital (KAUH) 
and Princess Basmah Hospital (PBH) in the city of Irbid 
located in North of Jordan.  The exclusion criteria was 
history of antibiotic intake over the past two months, 
regular use of antiseptic mouth wash, wearing remo-
vable dental prosthesis, pregnancy, anemia, or diabetes 
mellitus.   Subjects with a current or history of any der-
matological disease (other than psoriasis for the study 
group) were also not included.  The control subjects 
closely matched for age and gender were selected from 
the hospital staff and the companions of the patients at 
KAUH who were biologically not related to the study 
group subjects.  The control subjects fulfilled the same 
selection criteria for the study group except the history 
of psoriasis.  
A subject was classified as “smoker” when he / she re-
ported smoking at least one cigarette daily. The “non-
smoker” was defined as either never had smoked, or who 
had quit smoking for at least one year prior to the stu-
dy (13).  The Hospital Anxiety and Depression (HAD) 
questionnaire (14), and the Dermatology Life Quality 
Index (DLQI) (15) was filled by psoriatic patients.
Clinical oral examination was carried out by a one of the 
authors (AAB) while the subject seated on a chair using 
artificial light and sterile mirrors, and the diagnosis of 
oral mucosal lesions was made on a clinical basis accor-
ding to the method and criteria proposed by WHO (16). 
The swab and smear tests were performed on lesions su-
ggestive for oral candidosis. The swabs were streaked on 
Sabouraud’s dextrose agar plates (Oxoid Ltd, Basings-
toke, England) and incubated aerobically at 37º C for 
48 hours.  Candida colonies were identified based on 
the colony color, texture and morphology, and determi-
nation of the purity of the culture was then performed 
microscopically by the wet mount technique at X40 ob-
jective.  Candida species were identified using the germ-
tube test (17) and the VITEK 2® Identification System 
using the new colorimetric yeast cards (18) (BioMerieux 
Inc. Durham NC, USA).  Smears were Gram stained and 
examined under light microscope at X40 objectives for 
the presence of fungal hyphae or blastospores.  Candida 
isolation and identification was performed in the Mi-
crobiology Laboratory in KAUH. Oral candisosis was 
finally diagnosed when the subject exhibited the clinical 
signs and symptoms of oral candidosis in addition to the 
positive isolation of Candida species from the swab cul-
ture samples, and Candida blastospores or hyphae were 
detected in the stained smear.
The severity of psoriasis was assessed by the Psoriasis 
Area and Severity Index (PASI) score which was cal-
culated for the psoriatic patient by the treating derma-
tologist.  According to the PASI score the severity of 
psoriasis was categorized as “mild” when the total score 
calculated was < 10, “moderate” when the total score 
was within the range of 10-20 and “severe” when the to-
tal score was > 20 (19).  The DLQI (15) categorizes the 
effect of psoriasis on the quality of the psoriatic patient 
life of into:
1) No effect: score = 0-1
2) Small effect: score = 2-5
3) Moderate effect: score = 6-10
4) Very large effect: score = 11-20
5) Extremely large effect: score = 21-30
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microbiologic evidence of oral candidosis were two ca-
ses of erythematous candidosis and one case of median 
rhomboid glossitis, and all caused by Candida albicans. 
These three patients were under topical betamethaso-
ne (Daivobet®) therapy, of the plaque type psoriasis, 
and non-smokers, and were subsequently referred for 
treatment.
Due to the small number of patients presented with ty-
pes of psoriasis other than the plaque type (≤ 5 patients), 
the patients were divided into two main subgroups; the 
plaque type and non-plaque type psoriasis. The results 
showed that the clinical type of psoriasis, the duration of 
the disease or the method of disease management (me-
dicated vs. non-medicated for psoriasis), or the smoking 
habit did not influence the prevalence of FT and GT (Ta-
ble 1).
Only 87 psoriatic patients and 88 control subjects com-
pleted the HAD scale form.  The psoriatic patients with 
categorized with significant level of depression and 
anxiety had relatively higher prevalence of FT and GT 
but this have not reached significance (Table 2).
The prevalence of FT and GT was also relatively higher 
among patients with severe psoriasis as assessed with 
PASI scores, nevertheless the difference was not signi-
ficantly different that the prevalence in less severe cases 
(Table 2).  Psoriatic patients who experienced very large 
to extremely large adverse effect of psoriasis on their 
quality of life have significantly higher prevalence of 
GT (p= 0.04; Table 2).
All patients were interviewed concerning their relevant 
medical and social history.
This study protocol was approved by the Institutional 
Review Board (IRB) at KAUH in compliance with the 
Helsinki Declaration, and all subjects signed the consent 
form which was also approved by the IRB.
Data were analyzed using the Statistical Package for the 
Social Sciences (SPSS) version 17.0. Categorical varia-
bles were evaluated using Chi-square test or Fisher’s 
exact test with overall significance set at p < 0.05.
Results
Each of the study and control groups consisted of one 
hundred subjects with a mean age of 32.9 ± 14.8 years. 
Each group consisted of 54 males (54%) and 46 fema-
les (46%). The mean duration of psoriasis was 10 ± 8.5 
years ranging between 1.5 months and 43 years.
Oral mucosal lesions were diagnosed in 43 (43%) pso-
riatic patients and 17 (17%) control subjects (p=0.000). 
Comparing psoriatic patients to control subjects the 
prevalence of fissured tongue (FT) was 35% vs. 13% 
(p=0.000); geographic tongue (GT) 17% vs. 9% (p=0.09); 
combination of FT and GT 5% vs. 5% (p=1.00); oral 
candidosis 3% vs. 0% (p=0.81); leukoedema 1% vs. 3% 
(p=0.62); physiologic melanin pigmentations 4% vs. 1% 
(p=0.37) respectively.  Due to relatively low prevalence 
of some oral lesions, further statistical analysis and asso-
ciations were only to the results of FT and GT.  
The three psoriatic patients who showed clinical and 
Psoriasis category Fissured tongue Geographic tongue
n (%) n (%)
Plaque type (n= 85)
Non-plaque type (n=15)
30 (35.3) 15 (17.6)
5 (33.3) 2 (13.3)
p-value 0.88 0.68
Early-onset psoriasis (<30 years)   (n= 72) 
Late-onset psoriasis (≥30 years)   (n= 28)
21(29.2)
14 (50.0)
15(20.8)
  2 ( 7.1)
p-value 0.05 0.10
Duration <10 years (n= 51) 
Duration ≥ 10 years (n= 49)
17 (33.3)
18 (36.7)
10 (19.6)
7 (14.3)
p-value 0.71 0.48
Not medicated (n= 21)
Medicated (n= 79)
6 (28.6)
29 (36.7)
2 (9.5)
15 (19.0)
p-value 0.49 0.30
Smokers (n=33)`
Non-smokers (n=67)
12 (36.4)
23 (34.3)
6 (18.2)
11 (16.4)
p-value 0.84 0.82
Table 1. The relationship of fissured tongue and geographic tongue to the different clinical parameters in psoriatic 
patients.
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Discussion
Despite psoriasis is a common skin disorder, reviewing 
the literature reveals that reports of it involving the oral 
mucosa are relatively rare, with less than 100 publica-
tions (20). In addition, weather these oral mucosal le-
sions are representing true oral manifestations of the 
disease (10), or not (4,20) is still controversial. This is 
possibly because mucosal biopsy is seldom done for 
these oral lesions, and the correlation between the oral 
lesions and the clinical course of skin psoriasis has not 
been established.  Our closely-matched controlled study 
has lent support to the theory that psoriatic patients in 
general are presented with more oral lesions than non-
psoriatic subjects (21).
According to the results of our study on this group of 
Jordanian psoriatic patients, FT was the most common 
oral finding, and significantly more frequent in psoriatic 
patients than controls, which confirms the results of other 
studies in other populations (2,3,21,22). Our findings that 
35% prevalence of FT in psoriatic patients falls within 
the range of 6% to 47.5% reported in different studies 
(2,3,6,9,22,23) and in accordance to Costa et al. (2) and 
Germi et al. (21) who reported FT in 34.3% and 35.1% 
of their psoriatic patients respectively. In addition, the 
prevalence of FT among our control subjects (13%) was 
very close to that previously reported among Jordanians 
(11.5%) (24), which gives validity to the results.
Considering the possibility of the presence of a shared 
genetic basis for psoriasis and FT is one of the possible 
explanations for the frequent occurrence of FT in psoria-
tic patients (2), and encouraged the researchers to hypo-
thesize that FT may be an oral manifestation of psoriasis 
(2).  Such conclusion should be considered with caution 
since a recent study could not demonstrate a common 
genetic factor in psoriasis and FT (25), and the histo-
pathological or clinical parallelism with the cutaneous 
psoriasis is still unproven. The precise relationship of 
FT to psoriasis is still unclear.  The finding of marginally 
significant high prevalence of FT in patients with late 
onset psoriasis compared to early onset disease (50% 
and 29.2% respectively; p=0.05) may be partly explai-
ned by the reported successively increasing prevalence 
of FT with advancing age (24).
The prevalence of GT in our psoriatic patients (17%) 
is slightly higher than the prevalence range reported in 
other studies (1.3%-14.0%) (3,6,8,9,22,23). This may be 
due to differences in age, gender and type of psoriasis 
distribution in the population studied. However, the pre-
cise prevalence of GT may be difficult to determine sin-
ce this study, and the other studies, were cross-sectional, 
and cases of GT are known to be subjected to flare ups 
and remissions with time.  Therefore, future longitudi-
nal, rather than cross-sectional, studies are encouraged 
if the relationship between GT and psoriasis is to be elu-
cidated.
Consistent with our results, Shulman and Carpenter (4) 
and Miloğlu et al. (5) could not find a significant diffe-
rence in the prevalence of GT between psoriatic patients 
and control subjects.  On the contrary, multiple surveys 
reported a significant higher prevalence of GT in psoria-
tic patients (2,7,9).  One histopathological study biop-
sied GT lesions in psoriatic patients and control subjects 
Patients category Fissured tongue
n (%)
Geographic tongue
n (%)
Anxiety category
  Normal-to-border (n=55)
  Significant (n=32)
18 (32.7)
15 (46.9)
8 (14.6)
7 (21.9)
p-value 0.19 0.38
Depression category
  Normal-to-border  (n=73)
  Significant (n=14)
26 (35.6)
  7 (50.0)
11 (15.1)
  4 (28.6)
p-value 0.31 0.22
DLQI category
  No - small effect (n=24)
  Moderate effect (n=24)
  Vary large to extremely large effect 
(n=39)
  9 (37.5)
  9 (37.5)
15 (38.5)
  2 (  8.3)
  2 (  8.3)
11 (28.2)
p-value 0.99 0.04
PASI category
  Mild (n=61)
  Moderate (n=18)
  Severe (n=10) 
22 (36.1)
  4 (22.2)
  5 (50.0)
12 (19.7)
  1 (  5.6)
  4 (40.0)
p-value 0.31 0.63
Table 2. The relationship of fissured tongue and geographic tongue to the various categories of psoriatic patients.
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and described typical features of psoriasis in all cases 
from psoriatic patients but in 80% of the control sub-
jects, hence concluded that GT is an expression of oral 
psoriasis (7).
There was much debate concerning the relationship bet-
ween the psoriasis clinical type and oral lesions. Costa et 
al. (2) could not find an association between the type of 
psoriasis and the presence of oral lesions which is con-
sistent with our study.  Some studies reported higher pre-
valence of FT in generalized pustular psoriasis (9,11), 
psoriasis erythroderma (9) and plaque type psoriasis (3). 
However, the analysis of the prevalence of oral lesions 
by psoriasis clinical type was limited in the current study 
since the patients were divided as plaque type and non-
plaque type due to the small number of patients presen-
ted with types of psoriasis other than the plaque type. 
Tobacco smoking is associated with numerous derma-
tologic conditions including psoriasis (26).  The preva-
lence of FT and GT in our psoriatic patients was almost 
equal in non-smokers and smokers which was also the 
finding of other studies (3), while others found that GT 
had a low prevalence in smokers (22).
Within this limited number of psoriatic patients, there is 
a tendency for the prevalence of FT and GT to correla-
te positively, though not significantly, with the patient’s 
anxiety and depression category.  GT is significantly 
higher in patients whom psoriasis had severe impact on 
their life.  In general, it is widely accepted that GT le-
sions exacerbate after stressful events and this implies 
that this lesion is related to emotional stress with a thres-
hold of susceptibility to anxiety (27).  Nevertheless, we 
could not detect a significant positive correlation bet-
ween the severity of the psoriasis and the prevalence of 
any of the oral lesions on contrary to Daneshpazhooh et 
al. (9) who reported increased frequency of GT with in-
creased severity of psoriasis only in patients with plaque 
type psoriasis.
The literature on the oral candidosis in patients with 
psoriasis is limited.  Henseler and Tausch (28) reviewed 
the medical records of 44695 dermatological patients 
and concluded that psoriatic patients had 1.3-1.6 relative 
risk of developing mucocutaneous candidosis compa-
red to healthy persons.  Skinner et al. (29) reported 14 
psoriatic patients in whom the disease was associated 
with oro-pharyngeal Candida.  Angular cheilitis was 
reported in 11% (23) and erythematous candidosis and 
pseudomembranous candidosis (3) in 7.5% and 1.2% of 
the psoriatic patients respectively.  Our finding of oral 
candidosis in 3% of psoriatic patients but in none of the 
healthy control subjects supports the view that psoriatic 
patients may be predisposed for oral candidosis (3). It is 
noteworthy that all the three cases were on topical be-
tamethasone (Daivobet®) therapy for their skin disease. 
Nevertheless, this finding needs to be confirmed and the 
predisposing factor(s) to be identified.
In conclusion, there is a consensus that some oral mu-
cosal lesion such as FT and GT are strongly associated 
with psoriasis.  Although these lesions are non-pathog-
nomonic to psoriasis, their precise relationship needs to 
be clarified, and weather they constitute the oral coun-
terpart of the cutaneous lesions await further studies. 
Oral health care provider should aware of the liability of 
psoriatic patients to oral candidal infection.
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